Menu Close

Author: WorkCompAcademy

MIT Researchers Study Why Laws are Written in an Incomprehensible Style

Legal documents are notoriously difficult to understand, even for lawyers. This raises the question: Why are these documents written in a style that makes them so impenetrable?

MIT cognitive scientists believe they have uncovered the answer to that question. Just as “magic spells” use special rhymes and archaic terms to signal their power, the convoluted language of legalese acts to convey a sense of authority, they conclude.

In a study appearing this week in the journal of the Proceedings of the National Academy of Sciences, the researchers found that even non-lawyers use this type of language when asked to write laws.

“People seem to understand that there’s an implicit rule that this is how laws should sound, and they write them that way,” says Edward Gibson, an MIT professor of brain and cognitive sciences and the senior author of the study. Eric Martinez PhD ’24 is the lead author of the study. Francis Mollica, a lecturer at the University of Melbourne, is also an author of the paper.

Gibson’s research group has been studying the unique characteristics of legalese since 2020, when Martinez came to MIT after earning a law degree from Harvard Law School. In a 2022 study, Gibson, Martinez, and Mollica analyzed legal contracts totaling about 3.5 million words, comparing them with other types of writing, including movie scripts, newspaper articles, and academic papers.

That analysis revealed that legal documents frequently have long definitions inserted in the middle of sentences – a feature known as “center-embedding.” Linguists have previously found that this kind of structure can make text much more difficult to understand. “Legalese somehow has developed this tendency to put structures inside other structures, in a way which is not typical of human languages,” Gibson says.

In a follow-up study published in 2023, the researchers found that legalese also makes documents more difficult for lawyers to understand. Lawyers tended to prefer plain English versions of documents, and they rated those versions to be just as enforceable as traditional legal documents. “Lawyers also find legalese to be unwieldy and complicated,” Gibson says. “Lawyers don’t like it, laypeople don’t like it, so the point of this current paper was to try and figure out why they write documents this way.”

The researchers had a couple of hypotheses for why legalese is so prevalent. One was the “copy and edit hypothesis,” which suggests that legal documents begin with a simple premise, and then additional information and definitions are inserted into already existing sentences, creating complex center-embedded clauses.

“We thought it was plausible that what happens is you start with an initial draft that’s simple, and then later you think of all these other conditions that you want to include. And the idea is that once you’ve started, it’s much easier to center-embed that into the existing provision,” says Martinez, who is now a fellow and instructor at the University of Chicago Law School.

However, the findings ended up pointing toward a different hypothesis, the so-called “magic spell hypothesis.” Just as magic spells are written with a distinctive style that sets them apart from everyday language, the convoluted style of legal language appears to signal a special kind of authority, the researchers say. “In English culture, if you want to write something that’s a magic spell, people know that the way to do that is you put a lot of old-fashioned rhymes in there. We think maybe center-embedding is signaling legalese in the same way,” Gibson says.

In this study, the researchers asked about 200 non-lawyers (native speakers of English living in the United States, who were recruited through a crowdsourcing site called Prolific), to write two types of texts. In the first task, people were told to write laws prohibiting crimes such as drunk driving, burglary, arson, and drug trafficking. In the second task, they were asked to write stories about those crimes.

To test the copy and edit hypothesis, half of the participants were asked to add additional information after they wrote their initial law or story. The researchers found that all of the subjects wrote laws with center-embedded clauses, regardless of whether they wrote the law all at once or were told to write a draft and then add to it later. And, when they wrote stories related to those laws, they wrote in much plainer English, regardless of whether they had to add information later.

“When writing laws, they did a lot of center-embedding regardless of whether or not they had to edit it or write it from scratch. And in that narrative text, they did not use center-embedding in either case,” Martinez says.

In another set of experiments, about 80 participants were asked to write laws, as well as descriptions that would explain those laws to visitors from another country. In these experiments, participants again used center-embedding for their laws, but not for the descriptions of those laws.

Gibson’s lab is now investigating the origins of center-embedding in legal documents. Early American laws were based on British law, so the researchers plan to analyze British laws to see if they feature the same kind of grammatical construction. And going back much farther, they plan to analyze whether center-embedding is found in the Hammurabi Code, the earliest known set of laws, which dates to around 1750 BC.

“There may be just a stylistic way of writing from back then, and if it was seen as successful, people would use that style in other languages,” Gibson says. “I would guess that it’s an accidental property of how the laws were written the first time, but we don’t know that yet.”

The researchers hope that their work, which has identified specific aspects of legal language that make it more difficult to understand, will motivate lawmakers to try to make laws more comprehensible. Efforts to write legal documents in plainer language date to at least the 1970s, when President Richard Nixon declared that federal regulations should be written in “layman’s terms.” However, legal language has changed very little since that time. “We have learned only very recently what it is that makes legal language so complicated, and therefore I am optimistic about being able to change it,” Gibson says.

Separate Public Entities Exempt From Wage Order and PAGA Claims

All California counties have a mandatory duty to provide medical care for their indigent residents.

After years of managing a medical center for this purpose, the Alameda County Board of Supervisors (Board of Supervisors) determined that transferring governance of the center to a hospital authority would “improve the efficiency, effectiveness, and economy of the community health services provided” and would be “the best way to fulfill its commitment to the medically indigent, special needs, and general populations of” the county.

The Board of Supervisors sought the legislative authorization to do so. In 1996 the Legislature enacted Health and Safety Code, section 101850 which authorized the establishment of defendant Alameda Health System (AHS) as a “separate public agency” (Health & Saf. Code, § 101850, subd. (a)(2)(C); see id., subd. (a)(2)(D)) “strictly and exclusively dedicated to the management, administration, and control of the medical center.”

Plaintiffs worked at Highland Hospital, a facility operated by AHS. Tamelin Stone was a medical assistant and Amanda Kunwar was a licensed vocational nurse. In their wage and hour suit against AHS, plaintiffs alleged these positions were subject to requirements of the Labor Code and wage orders, in particular Industrial Wage Commission (IWC) wage order No. 5-2001 (Cal. Code Regs., tit. 8, § 11050).

The operative complaint alleged that AHS frequently denied or discouraged the taking of meal and rest breaks and “automatically deducted ½ hour from each workday” even when meal periods were not taken.

AHS demurred on the ground that it was a public entity not subject to suit for the Labor Code violations asserted. The demurrer was sustained without leave to amend.

The Court of Appeal reversed in part, reasoning that construing the enabling statute, rather than the Labor Code provisions themselves, the court discerned no legislative intent to exempt AHS from the meal and rest period and payroll requirements underlying plaintiffs’ first three causes of action. (Stone v. Alameda Health System (2023) 88 Cal.App.5th 84, 93-94 (Stone).)

The California Supreme Court reversed in Stone v. Alameda Health System -S279137 (August 2024).

The Labor Code and wage order impose meal and rest break obligations on “employers,” and, under the relevant wage order, an “employer” must be a “person as defined in Section 18 of the Labor Code.” (Wage Order No. 5, subd. 2(H).) Accordingly, section 18’s definition of the term “person” is central to resolving the issues here.

However the Supreme Court went on to say “While section 18’s definition of ‘person’ is central to our interpretation of the relevant Labor Code and wage order provisions, this definition by itself is not dispositive.”

Wage Order No. 5, which covers hospital workers, states that, unless specifically noted otherwise, “the provisions of this order shall not apply to any employees directly employed by the State or any political subdivision thereof, including any city, county, or special district.” (Wage Order No. 5, subd. 1(C).) The plain language of the governing wage order thus expressly excludes public employers from most of the wage and hour obligations it places on private employers, including meal and rest break obligations.

Relevant history of the statutes and wage orders also supports a conclusion that the Legislature did not intend for meal and rest break requirements to apply to public employers.”

“Plaintiffs largely concede that the Labor Code provisions at issue are generally not applicable to public employers. Their primary argument is that the provisions apply to AHS because AHS is not a public entity.”

The enabling statute repeatedly describes AHS as a public agency. In a subdivision devoted to definitions, it states that – Hospital Authority means the separate public agency established pursuant to the enabling legislation.

Accordingly, as a public employer, AHS is not a ‘person’ subject to liability for the meal and rest break and associated payroll records violations alleged in plaintiffs’ complaint.” In addition “based on the statutory text, legislative history, and public policy, we conclude public entity employers are not subject to PAGA suits for civil penalties.”

Huntington Beach Company Succeeds With First Artificial Heart Transplant

In a groundbreaking medical achievement, the first fully mechanical heart developed by Huntington Beach based BiVACOR®, has been successfully implanted in a human patient. This milestone marks a significant advancement in the field of cardiac care, offering new hope for those awaiting heart transplants.

The Texas Heart Institute and BiVACOR®, a clinical-stage medical device company, announced the successful first-in-human implantation of the BiVACOR Total Artificial Heart (TAH) as part of the U.S. Food and Drug Administration (FDA) Early Feasibility Study (EFS).

BiVACOR’s TAH is a titanium-constructed biventricular rotary blood pump with a single moving part that utilizes a magnetically levitated rotor that pumps the blood and replaces both ventricles of a failing heart. The non-contact suspension of the rotor via maglev is designed to eliminate the potential for mechanical wear and provide large blood gaps that minimize blood trauma, offering a durable, reliable, and biocompatible heart replacement. With activity, the device is auto-regulated to provide up to 12 liters of blood flow per minute, which is similar to that pumped by a healthy human heart.

The first-in-human clinical study aims to evaluate the safety and performance of the BiVACOR TAH as a bridge-to-transplant solution for patients with severe biventricular heart failure or univentricular heart failure in which left ventricular assist device support is not recommended. Following this first implantation completed at Baylor St. Luke’s Medical Center in the Texas Medical Center into a critically ill 57-year-old man who was in cardiogenic shock and awaiting a heart transplant. Four additional patients are to be enrolled in the study.

The nearly six-hour operation allowed the patient to be liberated from the vent on post-operative day three, and sit in a chair that same day. On post-op day seven, he could ambulate 150 meters. On July 17, eight days after the implant, a donor heart became available. The patient celebrated his 58th birthday and he is reported to be continuing to recover from the transplant in the hospital.

“The Texas Heart Institute is enthused about the groundbreaking first implantation of BiVACOR’s TAH. With heart failure remaining a leading cause of mortality globally, the BiVACOR TAH offers a beacon of hope for countless patients awaiting a heart transplant,” said Dr. Joseph Rogers, President and Chief Executive Officer of The Texas Heart Institute and National Principal Investigator on the research. “We are proud to be at the forefront of this medical breakthrough, working alongside the dedicated teams at BiVACOR, Baylor College of Medicine, and Baylor St. Luke’s Medical Center to transform the future of heart failure therapy for this vulnerable population.”

Daniel Timms, PhD, Founder and Chief Technology Officer of BiVACOR said, “I’m incredibly proud to witness the successful first-in-human implant of our TAH. This achievement would not have been possible without the courage of our first patient and their family, the dedication of our team, and our expert collaborators at The Texas Heart Institute. Utilizing advanced MAGLEV technology, our TAH brings us one step closer to providing a desperately needed option for people with end-stage heart failure who require support while waiting for a heart transplant. I look forward to continuing the next phase of our clinical trial.”

Heart failure is a global epidemic affecting at least 26 million people worldwide, 6.2 million adults in the U.S., and is increasing in prevalence. Heart transplantations are reserved for those with severe heart failure and are limited to fewer than 6,000 procedures per year globally. Consequently, the U.S. National Institutes of Health estimated that up to 100,000 patients could immediately benefit from mechanical circulatory support (MCS), and the European market is similarly sized.

The successful implantation of BiVACOR’s TAH highlights the potential of innovative technologies to address critical challenges in cardiac care, such as long transplantation waitlists. BiVACOR and The Texas Heart Institute remain committed to advancing the field of cardiac medicine and improving outcomes for patients worldwide.

Conspiracy and Fraud Charges Added Against Bio-Lab Operator

The operator of a Reedley lab, who was indicted in November 2023, faces additional charges of conspiracy and wire fraud after a federal grand jury returned a 12-count superseding indictment on August 15.

Jia Bei Zhu, 62, a citizen of China, was previously indicted for distributing adulterated and misbranded COVID-19 test kits in violation of the federal Food, Drug, and Cosmetic Act and making false statements to authorities about his identity and involvement with the biolabs.

The superseding indictment also charges Zhu’s romantic and business partner, Zhaoyan Wang, 38, a citizen of China, who operated the biolabs Universal Meditech Inc. (UMI) and Prestige Biotech Inc. (PBI) in Fresno and Reedley along with Zhu. UMI and PBI distributed COVID-19, pregnancy, and other types of test kits.

According to court documents, from August 2020 through March 2023, Zhu and Wang conspired to defraud buyers of UMI and PBI’s COVID-19 test kits. They imported hundreds of thousands of COVID-19 test kits from Ai De Ltd., which was a company in China that they controlled, and falsely represented to the buyers that the test kits were made in the United States. They illegally imported the COVID-19 test kits, which they were not approved to import, by falsely declaring them as pregnancy test kits, which they were approved to import.

Zhu and Wang also falsely represented to the buyers that UMI and PBI could make up to 100,000 COVID-19 test kits per week in the United States and that the test kits were made in connection with other labs that were certified by the Centers for Disease Control and Prevention. Finally, they falsely represented to the buyers that the test kits were approved by the Food and Drug Administration (FDA). Zhu and Wang made over $1.7 million through their fraud.

When buyers requested to inspect UMI and PBI’s facilities in Fresno and Reedley, Zhu and Wang denied them access and fabricated reasons for the denial. The fabricated reasons included that the facilities were undergoing construction and renovation, and that proprietary and confidential information and technology was inside. In reality, however, they did not want the buyers to know that UMI and PBI were obtaining the COVID-19 test kits from China.

Zhu is currently detained in custody pending his federal trial. His next status conference is scheduled for Sept. 11, 2024. Wang is not in custody.

If convicted, Zhu and Wang each face maximum statutory penalties of 20 years in prison for the conspiracy and wire fraud charges, and an additional three years in prison for the distribution of adulterated and misbranded medical device charges. Zhu also faces another five years in prison for the false statements charge. Any sentences, however, would be determined at the discretion of the court after consideration of any applicable statutory factors and the Federal Sentencing Guidelines, which take into account a number of variables. The charges are only allegations. Zhu and Wang are presumed innocent until and unless proven guilty beyond a reasonable doubt.

This case is the product of an investigation by the Federal Bureau of Investigation and the FDA Office of Criminal Investigations. Assistant U.S. Attorneys Arelis Clemente, Joseph Barton, and Henry Carbajal III are prosecuting the case.

New CIGA Board and WCIRB Governing Committee Members Announced

The California Insurance Commissioner announced several appointments including naming Timothy Hyamn as the newest member of the California Insurance Guarantee Advisory (CIGA) Board of Directors, Bryan Little as the newest member of the Workers’ Compensation Insurance Rating Bureau (WCIRB) Governing Committee, Michael Golden and Nona Tirre Mirande as reappointed members to the California Automobile Assigned Risk Plan (CAARP) Advisory Board, and Ophir Bruck, Stephanie Chan, and Thomas Connell Wilson as reappointed members to the California Organized Investment Network (COIN) Advisory Board.

The Governor and California State Legislature created CAARP to provide auto insurance for motorists unable to obtain coverage in the private market due to their driving records or other extraordinary circumstances. One program within the plan — the California Low Cost Auto Program — aims to provide affordable liability insurance to income-eligible good drivers by assigning them to private insurers based upon the companies’ share of the auto insurance market. The CAARP Advisory Committee provides policy advice to Commissioner Lara on matters affecting the operation of its programs.

The CIGA Board of Governors oversees the guarantee association’s general operations and management in order to protect policyholders in the event of an insurance company insolvency. Established in 1969 by the Governor and California State Legislature, CIGA comprises all insurance companies admitted to sell homeowners, workers’ compensation, automobile, and other specified property and casualty lines of insurance in California.

The California Organized Investment Network (COIN) was established in 1996 within the Department of Insurance to guide insurers on making financially sound investments that yield environmental benefits throughout California and social benefits within the State’s underserved communities. Commissioner Lara has prioritized COIN investments which drive affordable housing, support small businesses, combat climate change, and encourage investors to utilize diverse investment managers more. The COIN Advisory Board provides guidance to the Commissioner and the COIN program to meet its mission and chief priorities.

The WCIRB Governing Committee sets policy, oversees WCIRB management, and reviews all issues involving pure premium rates, classifications, rating plans, rating systems, manual rules and policy, and endorsement forms. The WCIRB is a private organization licensed by the Department for the purpose of collecting, analyzing, and compiling rating data, with funding coming from assessments of its insurance company members. All workers’ compensation insurance companies in California are required by law to be members of the WCIRB.  

The next CAARP Advisory Committee meeting is August 20 and August 21, 2024, the next CIGA Board of Governors meeting is August 13 and August 14, 2024, the next COIN Advisory Board meeting is November 7, 2024, and the next WCIRB Governing Committee meeting is September 25, 2024.

More details are available at: www.insurance.ca.gov/boards. Public members of the CAARP Advisory Committee receive $250 per meeting. All other positions are uncompensated.

Proposed Law Strengthens Review of Private Equity Healthcare Buyouts

Current law establishes the Office of Health Care Affordability (OHCA) in the Department of Health Care Access and Information (HCAI), which is responsible for analyzing the health care market for cost trends and drivers of spending, developing data-informed policies for lowering health care costs for consumers and purchasers, creating a state strategy for controlling the cost of health care and ensuring affordability for consumers and purchasers, and enforcing cost targets.

Current law requires a health care entity to provide OHCA with written notice of agreements or transactions that will occur on or after April 1, 2024, at least 90 days prior to entering into an agreement to do either of the following: sell, transfer, lease, exchange, option, encumber, convey, or otherwise dispose of a material amount of its assets to one or more entities; or,transfer control, responsibility, or governance of a material amount of the assets or operations of the health care entity to one or more entities.

Healthcare groups, unions and hospitals are weighing in on a proposed bill in California, AB-3129, that would strengthen review of private equity deals in healthcare. California Attorney General Rob Bonta and Assembly Speaker Pro Tempore Jim Wood introduced the bill in February. It remains pending in the state Legislature.

According to the author, Private Equity acquisitions in health care have exploded in the past decade. From 2013 to 2016, PE firms acquired 355 physician practices. In the four years that followed, PE acquired 578 additional practices and has poured nearly $1 trillion into nearly 8,000 health care transactions during the past decade.

More than 90% of PE consolidations fall below the $101 million threshold that triggers an antitrust review by the Federal Trade Commission and the U.S. Justice Department. The author states that emerging data shows these acquisitions demand attention and increased regulatory oversight to ensure that these transactions are in the public interest.

These PE firms aim to secure high returns on their investments, as much as 20% in just three to five years, by making them more lucrative, which can conflict with the goal of delivering affordable, accessible, high- value health care.

The authors claim that studies “consistently show that PE ownership in the health care industry has resulted in higher health care costs, poor quality and less access to care. The author concludes that transparency and scrutiny of these deals is needed because without proper oversight and regulation, these practices will continue and patients and consumers are likely to experience anticompetitive effects.

The authors cite a 2020 Journal of American Medicine article, “Private Equity Acquisitions of Physician Medical Groups Across Specialties,” that notes that PE has started to play a role in this consolidation in recent years. These firms typically invest in businesses by taking a majority stake with the goal of increasing the value of the business and potentially selling it at a profit. One study found that PE firms acquired 355 physician practices (1,426 sites and 5,714 physicians) from 2013 to 2016.

If passed, the bill would require private equity groups and hedge funds to notify the attorney general and obtain their written consent before a transaction with a healthcare facility, provider or provider group. It would also reinforce the existing prohibition on private equity groups and hedge funds interfering with the professional judgment of physicians, psychiatrists, or dentists in making healthcare decisions.

The California Hospital Association opposes the bill, saying it would add costs to the state and reduce healthcare access. “Unfortunately, the recently proposed amendments do not resolve CHA’s concerns and create new questions,” the group wrote in an Aug. 9 letter to the Senate Appropriations Committee. The letter states that the amendments do not remove hospitals from the bill and “go beyond private equity groups and hedge funds by imposing a new AG review process on nonprofit hospitals.”

The California Medical Association supports provisions of the bill that maintain the autonomy and integrity of the patient-physician relationship in medical decision-making.

The association wrote to lawmakers in support, stating: “Given the dangerous consequences PE has on cost, quality and access to care for all Californians, CMA respectfully requests that the bill move forward to ensure appropriate review of PE transactions and protect the patient-physician relationship against private equity in the healthcare delivery system.”

Other groups supporting the legislation include the California Academy of Family Physicians, California Dental Association, California Nurses Association, California Physicians Alliance and California Labor Federation. Other groups opposing the legislation include American Investment Council, Association of Dental Support Organizations and the California Chamber of Commerce.

WCAB Rejects Earnings Calculated With Hotel and Meal Reimbursement

Javier Hidalgo claimed injury to various body parts while employed by defendant Ducoing Management Inc., as a laborer on January 26, 2023.  On October 11, 2023, the matter proceeded to trial on several issues including earnings. The employee claimed $1,658.46 per week. The employer/carrier claimed $620.00 per week.

Hidalgo testified that he was hired to work full time, was to be provided lodging. He lived at a hotel during his employment, and would be at different locations. One week he would be in San Francisco and the following week in Sacramento. He agreed that the employer provided the lodging.

According to the Applicant, he was hired 3 months prior to his injury. On the first day of work he went to Modesto. He was taken there by a person and then on the same day at the end of the workday he was taken to Oakland. He was then provided lodging in Oakland. He was in Oakland for about a week. He was provided lodging the entire time he was in Oakland and given money for food. After being in Oakland, he went to Salinas and then Sacramento where the employer also provided food and lodging.

He estimated that he worked about 75 out of 90 days for the employer. He stated he was still provided a hotel by the employer for the 15 days he did not work. He worked in Bakersfield for about week. That is the last location he recalled working at.

Applicant was provided with lodging for the entire three month period and never went back home or to Orange County. During the three months he worked there if he had any mailed he used the foreman’s P.O. box in Oakland. He stated he was injured in Bakersfield which resulted in hospitalization for about a week at a trauma hospital then he was sent to a rehabilitation hospital. Thereafter, he went to stay with his sister.

About 15 years ago he worked with the same employer doing the same work and that lodging was not provided during that employment.

According to an employer’s witness, the Applicant stayed at hotels or lodges that the employer paid for. The employer did not give Applicant any money directly for lodging. Lodging was considered a business expense. The employer made the arrangements for lodging and covered for lodging outside of Anaheim. The employer would not cover for any lodging near Anaheim. Applicant was given a per diem check for food. The company only gave money for food to employees working off-site outside of Anaheim. The per diem for food was provided when traveling.

After a trial the WCJ found, in pertinent part, that applicant’s lodging and food allowance are considered part of his wages; that applicant’s weekly earnings are $1,439.10 a week.

The Defendant filed a Petition for Reconsideration, which contended in part that the WCJ erred in considering applicant’s lodging and food allowance as part of his wages. Reconsideration was granted in the panel decision of Hidalgo v Ducoing Management Inc -ADJ17503090 (March 2024).

Labor Code section 4453(c)(1), provides that “[w]here the employment is for 30 or more hours a week and for five or more working days a week, the average weekly earnings shall be the number of working days a week times the daily earnings at the time of the injury.” With respect to whether specific items, such as food and lodging, are included in the computation of average weekly earnings, the WCAB panel looked to section 4454 which states “average weekly earnings shall not include any sum which the employer pays to or for the injured employee to cover any special expenses entailed on the employee by the nature of his employment, .”

Remuneration is defined by Black’s Law Dictionary as “Payment; reimbursement. Reward; recompense; salary; compensation.” (Black’s Law Dict. (6th ed. 1990) p. 1296, col. 1.)

The analysis of whether lodging and meals are “remuneration” as opposed to “special expenses” is outlined in Burke v. Workers’ Comp. Appeals Bd. (2009) 74 Cal.Comp.Cases 359, as follows: In the context of employment, remuneration is payment or reward for services rendered. The plain meaning of “remuneration” does not include reimbursement for costs or expenses. When an employee’s expenses “entailed by the nature of [her] employment” are paid by an employer, an exchange of services for payment does not take place and the applicant does not obtain an advantage from the transaction. Determining whether fuel, lodging, and meals are “remuneration” or “special expenses” requires an analysis of several factors including whether they were provided in exchange for services, whether they are an advantage to the applicant, and whether they are provided to the applicant only while the applicant is performing employment duties.

With respect to meals, Burke provides the following: “Meals are remuneration if the employee is provided with meals in exchange for services and the meals are an economic advantage to applicant. For example, in Watson v. Workers’ Comp. Appeals Bd. (Ramirez) (1980) 45 Cal.Comp.Cases 50 (writ den.), the value of meals were included in the calculation of applicant’s earnings as a waitress. The applicant was relieved of the necessity of providing herself with the meals … and, therefore, her employer’s provision of the meals was an economic advantage to the applicant.”

Because all of Hildago’s “jobsites in 2022 and 2023 were away from home, it logically follows that applicant received a per diem for all of the days worked in 2022 and 2023. However, there was no evidence presented that the per diem for meals was part of his remuneration or understood to be an economic advantage to applicant above and beyond his wages.”

Turning to whether the cost of applicant’s lodging is remuneration for purposes of calculating his average weekly earnings, the WCAB noted that “the evidence is less clear cut.”

“Upon return, the WCJ should consider whether lodging was an expense necessitated by the nature of applicant’s employment, and whether payment for lodging provided any bargained for economic advantage to applicant.”

August 5, 2024 – News Podcast


Rene Thomas Folse, JD, Ph.D. is the host for this edition which reports on the following news stories: Cal Supreme Court Rules Uber-Lyft Proposition 22 is Not Unconstitutional. WCAB Affirms Take-Nothing in Rare Tick Bite – Lyme Disease Case. Supreme Ct. Rules Single Racial Epithet in 14 Years Sufficient for DFEH Claim. California and Other States Restaurant Wage Mandates Cause Job Losses. Proposed Law to Fine Insurers for “Ghost” Provider Networks. California DOI Announces Changes to State’s Insurer of Last Resort. WCIRB Issues 2024 State of the Workers’ Compensation System Report. 2 SoCal Hospitals Among 8 Nationwide Leading In Antimicrobial Stewardship.

JOEM Study Show the Value and Cost-Savings of MSK Digital Care Program

Chronic musculoskeletal (MSK) pain affects one in three individuals worldwide. MSK pain is a leading cause of work-related disability and productivity impairment, broadly impacting all industry sectors. Productivity impairment can occur through presenteeism (i.e. decreased work performance due to pain) and absenteeism (i.e. missing working hours), and can ultimately lead to early retirement, all imposing a strain to the workforce.

MSK pain-related productivity impairment drives tremendous economic impact at the organizational and societal levels. Total costs of MSK pain-related productivity loss represent up to $335 billion annual spent, outweighing the direct impact of healthcare expenditure.

Current guidelines recommend exercise-based physical therapy combined with education and behavioral interventions as a mainstay treatment for chronic MSK pain. However, insufficient healthcare facilities and professionals, the loss of work hours and travel expenses associated with attending in-person physical therapy sessions, leave many patients with suboptimal or no care. Digital interventions have arisen as a solution to increase access, promoting higher engagement, while driving clinically significant outcomes.

Additionally, evidence suggests that MSK digital interventions are more affordable than conventional in-person rehabilitation.Independently of care delivery mode (digital or in-person), most studies focused on cost-effectiveness from a societal perspective.To date, no study has explored the potential economic impact of digital interventions from an employer perspective.

For these reasons researchers decided to investigate the impact of a DCP in promoting savings associated with recovery of productivity impairment in employees with chronic MSK pain. As a secondary objective, to explore potential savings in different industry sectors. The Study – Recovering work productivity in a population with chronic musculoskeletal pain: unveiling the value and cost-savings of a digital care program – was just published in the Journal of Occupational and Environmental Medicine.

The DCP, developed according to current guidelines,consisted of home-based exercise, education, and cognitive behavioral therapy (CBT) over up to 12 weeks. During enrollment, each participant selected the physical therapist (PT) who supervised the intervention. During the onboarding video call, the PT performed a clinical assessment and prescribed a tailored program.

Exercise sessions were performed at the patient’s convenience (recommended 3 times/week) using an FDA-listed class II medical device composed of motion trackers, a dedicated tablet with a mobile app and a cloud-based portal. The tablet displayed guided exercise sessions through videos with real-time audio and visual biofeedback provided by the motion trackers. Motion data were stored in the cloud-based portal accessible by the assigned PT to asynchronously monitor and adjust the program as needed.

Patient education was provided through a smartphone app in the form of short written articles, focusing on the pathophysiology, pain reconceptualization, active coping skills, the role of exercise, and fear-avoidance behaviors.A CBT program based on mindfulness, acceptance, commitment therapy, and empathy-focused therapy was delivered through email in the form of interactive and audio modules. Patient and PT communication was fostered through a built-in secure chat within the smartphone app available on-demand.

From 11,361 patients screened for study eligibility, 5032 employees from 50 U.S. states started the program. Significant improvements in productivity impairment were observed across all industries, yielding median cumulative savings from $151 (95%CI 128;174) to $294 (95%CI 286;303) per participant at treatment-end. Twelve-months projections estimated median savings of $2916 (95%CI 2861;2972). Additionally, significant improvements in non-work-related daily activities were observed.

These savings, estimated from real-world data, disclosed the underlying burden of presenteeism, which was the major responsible for overall productivity loss. The observed results advocate for the use of a DCP to promote productivity recovery, and to improve quality of life in non-work-related activities, consequently supporting employers in maintaining a competitive workforce, while attaining significant savings.

NIH-Backed Research Finds Lab Tests Cannot Diagnose Long COVID

Postacute sequelae of SARS-CoV-2 infection (PASC), also known as long COVID, has been reported in millions of people worldwide and is a major public health burden. It is also a difficult problem for workers’ compensation claim administrators who have long COVID claims to adjust.

According to NIH-backed researchers writing in Annals of Internal MedicinePASC” is generally accepted as an umbrella term encompassing a wide spectrum of symptoms and health conditions that persist after acute SARS-CoV-2 infection, resulting in a major impact on quality of life. Although potential models of pathogenesis have been postulated, including immune dysregulation, viral persistence, organ injury, endothelial dysfunction, and gut dysbiosis, there are currently no validated clinical biomarkers of PASC.

As part of the National Institutes of Health’s RECOVER (Researching COVID to Enhance Recovery) Initiative, the researchers previously examined prospectively collected data from nearly 10,000 people in the RECOVER-Adult cohort with and without SARS-CoV-2 infection and identified 12 symptoms that best distinguish those with prior infection from those who are uninfected. They developed a PASC index based on these 12 symptoms, with 23% of the cohort with prior SARS-CoV-2 infection meeting this research threshold.

They further identified multiple clusters or subphenotypes of PASC. This framework does not encompass all people experiencing PASC but permits exploration of clinical laboratory features among those meeting the PASC threshold.

Routine clinical laboratory tests that accurately distinguish people with PASC from those without PASC might be useful in the diagnosis, prognosis, prevention, and treatment of PASC or its subtypes. Laboratory tests might also identify those who have persistent organ damage but minimal or no symptoms.

Studies have found potential biomarkers associated with PASC using mostly research-focused assays, but results have been inconsistent, perhaps due to different PASC study definitions; use of only selected biomarkers; choice of comparison groups, if any (people who have recovered from PASC or healthy control participants); duration of symptoms; types of symptoms or phenotypes; and patient population features, such as sex, age, race, vaccination status, comorbidities, and severity of initial infection.

Early small-cohort studies failed to find routine clinical biomarkers. There is a paucity of large studies examining the utility of standardized laboratory tests obtained in routine clinical care. For these reasons, these researchers decided to investigate clinical laboratory markers of SARS-CoV-2 and PASC.

Accordingly, the researchers conducted a study to determine whether SARS-CoV-2 infection led to persistent changes in results of common clinical laboratory tests, regardless of symptoms, in people with prior infection compared with those without prior infection. If so, laboratory studies could be used to augment symptom-based definitions of PASC.

The researchers analyzed 25 routinely used and standardized laboratory tests that were selected on the basis of availability across different institutions, prior literature, and clinical experience. These tests were prospectively done in Clinical Laboratory Improvement Amendments (CLIA) – certified laboratories with samples from 10,094 RECOVER-Adult participants representing a diverse cohort from across the United States.

Unfortunately overall, “no evidence was found that any of the 25 routine clinical laboratory values assessed in this study could serve as a clinically useful biomarker of PASC,or the specific type of PASC cluster.”

“In summary, our findings suggest that even highly symptomatic PASC may have no clinically observable objective findings on routine laboratory testing. Understanding the basic biological underpinnings of persistent symptoms after SARS-CoV-2 infection will likely require a rigorous focus on investigations beyond routine clinical laboratory studies (for example, transcriptomics, proteomics, metabolomics) to identify novel biomarkers.”